NEWS

 

Title Date
Oneness Biotech granted 2019 Asia Pacific Technology Fast 500TM award by Deloitte 2019-12-16
TFDA informs of collection of Active Pharmaceutical Ingredient License of PA-F4 (Plectranthus amboinicusextract-F4) 2019-12-13
BfArM accepts the IND application of Oneness Biotech for Phase 3 trial of diabetic foot ulcer new drug, ON101 (protocol#ON101CLCT04). 2019-04-01
Oneness Biotech to merge with Fountain Biopharma for enhancing competitiveness in global market 2019-03-08
Resolution made by Oneness Biotech’s Board for merger with Fountain BioPharma Inc. 2019-03-07